Loading…
Loading…

| JNJ | Johnson & Johnson | $255.63 | $615.4B |
| ABBV | AbbVie Inc. | $253.30 | $447.5B |
| MRK | Merck & Co., Inc. | $127.52 | $315.0B |
| NVS | Novartis AG | $153.08 | $291.0B |
| NVO | Novo Nordisk A/S | $48.19 | $214.1B |
| AMGN | Amgen Inc. | $366.05 | $197.6B |
| GILD | Gilead Sciences, Inc. | $130.34 | $161.8B |
| PFE | Pfizer Inc. | $24.83 | $141.5B |
| AZN | AstraZeneca PLC | $169.73 | $131.5B |
| SNY | Sanofi | $43.79 | $105.3B |